• Product NameBupivacaine hydrochloride
• Brief DescriptionInhibitors
• Purification99.48%
• Biological ActivityBupivacaine hydrochloride binds to the intracellular portion of voltage-gated sodium channels and blocks sodium influx into nerve cells, used for treating cardiac arrhythmias. Bupivacaine Hydrochloride is a local anaesthetic drug belonging to the amino amide group.
• Target NameProstaglandin Receptor inhibitor; Sodium Channel inhibitor
• CAS No. 18010-40-7
• Calculated MW 324.89
• Formulation C18H28N2OHCl
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Other
  SMILES:Cl.CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C
  Pathways:GPCR/G Protein; Membrane transporter/Ion channel
  Receptor:PGE2; Sodium Channel
  Boling pt:423.4C
  Melting pt:107.5C
  Solubility:Ethanol: 65 mg/mL (200.06 mM); Water: 23 mg/mL (70.79 mM); DMSO: 65 mg/mL (200.06 mM)
  Appearance:White Powder
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Sheets MF, et al. Trends Cardiovasc Med. 2010 Jan;20(1):16-21.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting